Hari Miskin

Hari Miskin has extensive work experience in the biotechnology and healthcare industry. Hari started working as an Associate at Opus Point Partners in 2011, where they specialized in healthcare and life science investing. Opus Point Partners is a hedge fund that supports biotechnology and healthcare companies in developing and commercializing innovative medicines and diagnostic tools. In 2012, Hari joined TG Therapeutics as the Chief Development Officer, a role they continue to hold.

Hari Miskin has a Master of Science (M.S.) degree in Biotechnology from The Johns Hopkins University. Hari also holds a Master of Science (M.S.) degree in Finance from Villanova University. In addition, Hari has a Bachelor of Science in Business Administration (B.S.B.A.) from Villanova University with a focus on Finance and Pre-Medical studies.